Companies · TNGX · Pharmaceutical Preparations

Tango Therapeutics, Inc. (TNGX)

Every material event, decoded in plain English — what each one means for the stock.

Aug 11, 2026$400M ATM authorization

ATM capacity jumps to $400M, expanding funding but dilution risk

Clinical momentum largely confirmed, but quarterly loss exceeded expectations

Executive Chair Weber exits five months early, ending the planned board transition

Open live on AllSight — the whole market, decoded →